Mohamed Iqbal

Discovery of a Potent, Selective, and Orally Active Proteasome Inhibitor for the Treatment of Cancer

Bruce D. Dorsey, Mohamed Iqbal, Sankar Chatterjee et al. · Journal of Medicinal Chemistry · 2008 · 146 citations · Full text

MCL-1Matrix maintains neuronal survival by enhancing mitochondrial integrity and bioenergetic capacity under stress conditions

Ujval Anilkumar, Mireille Khacho, Alexanne Cuillerier et al. · Cell Death and Disease · 2020 · 126 citations · Full text

Structure-guided identification of novel VEGFR-2 kinase inhibitors via solution phase parallel synthesis

Rabindranath Tripathy, Alyssa Reiboldt, Patricia A. Messina et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 104 citations · Full text

Medicinal Chemistry, Drug Target, Medicine +9

A New Class of Potent Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors:  Structure−Activity Relationships for a Series of 9-Alkoxymethyl-12-(3-hydroxypropyl)indeno[2,1-<i>a</i>]pyrrolo[3,4-<i>c</i>]carbazole-5-ones and the Identification of CEP-5214 and Its Dimethylglycine Ester Prodrug Clinical Candidate CEP-7055

Diane E. Gingrich, D. Rajagopala Reddy, Mohamed Iqbal et al. · Journal of Medicinal Chemistry · 2003 · 74 citations · Full text

Pharmacotherapy, Medicinal Chemistry, Angiogenesis +16

Potent Inhibitors of Proteasome

Mohamed Iqbal, Sankar Chatterjee, James C. Kauer et al. · Journal of Medicinal Chemistry · 1995 · 68 citations · Full text

Pharmaceutical Science, Quantitative Pharmacology, Proteasome +21